Baber U - Search Results

1

Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease.

Zafar MU, Baber U, Smith DA, Sartori S, Contreras J, Rey-Mendoza J, Linares-Koloffon CA, Escolar G, Mehran R, Fuster V, Badimon JJ. Zafar MU, et al. Among authors: baber u. Thromb Haemost. 2017 Oct 5;117(10):1981-1988. doi: 10.1160/TH17-04-0277. Epub 2017 Aug 24. Thromb Haemost. 2017. PMID: 28837213 Clinical Trial.

2

Cardiovascular risk factors in patients with chronic kidney disease.

van der Zee S, Baber U, Elmariah S, Winston J, Fuster V. van der Zee S, et al. Among authors: baber u. Nat Rev Cardiol. 2009 Sep;6(9):580-9. doi: 10.1038/nrcardio.2009.121. Epub 2009 Jul 21. Nat Rev Cardiol. 2009. PMID: 19621012 Review.

3

Anticoagulation for mechanical heart valves in patients with and without atrial fibrillation.

Baber U, van der Zee S, Fuster V. Baber U, et al. Curr Cardiol Rep. 2010 Mar;12(2):133-9. doi: 10.1007/s11886-010-0085-x. Curr Cardiol Rep. 2010. PMID: 20425168 Review.

4

How serious a problem is bleeding in patients with acute coronary syndromes?

Baber U, Kovacic J, Kini AS, Sharma SK, Dangas G, Mehran R. Baber U, et al. Curr Cardiol Rep. 2011 Aug;13(4):312-9. doi: 10.1007/s11886-011-0192-3. Curr Cardiol Rep. 2011. PMID: 21667168 Review.

5

Acute coronary syndromes: Antithrombotics in ACS--moving beyond unfractionated heparin.

Baber U, Mehran R. Baber U, et al. Nat Rev Cardiol. 2011 Sep 27;8(11):613-4. doi: 10.1038/nrcardio.2011.153. Nat Rev Cardiol. 2011. PMID: 21946778 No abstract available.

6

The fine balance of quality and quantity: the time has come to define quality of PCI!

Baber U, Mehran R. Baber U, et al. Catheter Cardiovasc Interv. 2011 Oct 1;78(4):503-4. doi: 10.1002/ccd.23356. Catheter Cardiovasc Interv. 2011. PMID: 21953747 No abstract available.

7

Prognostic significance of elevated baseline troponin in patients with acute coronary syndromes and chronic kidney disease treated with different antithrombotic regimens: a substudy from the ACUITY trial.

Acharji S, Baber U, Mehran R, Fahy M, Kirtane AJ, Lansky AJ, Stone GW. Acharji S, et al. Among authors: baber u. Circ Cardiovasc Interv. 2012 Apr;5(2):157-65. doi: 10.1161/CIRCINTERVENTIONS.111.963876. Epub 2012 Feb 21. Circ Cardiovasc Interv. 2012. PMID: 22354934 Clinical Trial.

8

Prevention of contrast-induced AKI--the ongoing saga.

Baber U, Mehran R. Baber U, et al. Nat Rev Nephrol. 2012 Mar 13;8(5):260-1. doi: 10.1038/nrneph.2012.57. Nat Rev Nephrol. 2012. PMID: 22410493

9

High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study.

Chirumamilla AP, Maehara A, Mintz GS, Mehran R, Kanwal S, Weisz G, Hassanin A, Hakim D, Guo N, Baber U, Pyo R, Moses JW, Fahy M, Kovacic JC, Dangas GD. Chirumamilla AP, et al. Among authors: baber u. JACC Cardiovasc Imaging. 2012 May;5(5):540-9. doi: 10.1016/j.jcmg.2011.12.019. JACC Cardiovasc Imaging. 2012. PMID: 22595163 Free PMC article.

10

Genotype-dependent impairment of hemoglobin clearance increases oxidative and inflammatory response in human diabetic atherosclerosis.

Purushothaman M, Krishnan P, Purushothaman KR, Baber U, Tarricone A, Perez JS, Wiley J, Kini A, Sharma SK, Fuster V, Moreno PR. Purushothaman M, et al. Among authors: baber u. Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2769-75. doi: 10.1161/ATVBAHA.112.252122. Epub 2012 Sep 13. Arterioscler Thromb Vasc Biol. 2012. PMID: 22982461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

380 results

Search Page